JPH04141054A - Preparation of modified wheat flour - Google Patents
Preparation of modified wheat flourInfo
- Publication number
- JPH04141054A JPH04141054A JP2262575A JP26257590A JPH04141054A JP H04141054 A JPH04141054 A JP H04141054A JP 2262575 A JP2262575 A JP 2262575A JP 26257590 A JP26257590 A JP 26257590A JP H04141054 A JPH04141054 A JP H04141054A
- Authority
- JP
- Japan
- Prior art keywords
- wheat flour
- fatty acid
- acid compound
- flour
- drying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013312 flour Nutrition 0.000 title claims abstract description 83
- 241000209140 Triticum Species 0.000 title claims abstract description 58
- 235000021307 Triticum Nutrition 0.000 title claims abstract description 58
- -1 fatty acid compound Chemical class 0.000 claims abstract description 54
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 53
- 239000000194 fatty acid Substances 0.000 claims abstract description 53
- 229930195729 fatty acid Natural products 0.000 claims abstract description 53
- 229920002472 Starch Polymers 0.000 claims abstract description 26
- 235000019698 starch Nutrition 0.000 claims abstract description 26
- 239000008107 starch Substances 0.000 claims abstract description 26
- 239000002904 solvent Substances 0.000 claims abstract description 25
- 238000001035 drying Methods 0.000 claims abstract description 21
- 238000004519 manufacturing process Methods 0.000 claims description 19
- 238000001291 vacuum drying Methods 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000009777 vacuum freeze-drying Methods 0.000 claims 1
- 229920000856 Amylose Polymers 0.000 abstract description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 9
- 238000010521 absorption reaction Methods 0.000 abstract description 8
- 230000029087 digestion Effects 0.000 abstract description 8
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 abstract description 2
- 230000036541 health Effects 0.000 abstract description 2
- 229960002446 octanoic acid Drugs 0.000 abstract description 2
- 239000000523 sample Substances 0.000 description 14
- 235000013305 food Nutrition 0.000 description 13
- 238000000034 method Methods 0.000 description 13
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 12
- 229910052740 iodine Inorganic materials 0.000 description 12
- 239000011630 iodine Substances 0.000 description 12
- 208000008589 Obesity Diseases 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 235000020824 obesity Nutrition 0.000 description 7
- 239000002253 acid Substances 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 235000013325 dietary fiber Nutrition 0.000 description 4
- 235000019621 digestibility Nutrition 0.000 description 4
- 238000004108 freeze drying Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000003111 delayed effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 229920002261 Corn starch Polymers 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- SZYSLWCAWVWFLT-UTGHZIEOSA-N [(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl octadecanoate Chemical compound O([C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@]1(COC(=O)CCCCCCCCCCCCCCCCC)O[C@H](CO)[C@@H](O)[C@@H]1O SZYSLWCAWVWFLT-UTGHZIEOSA-N 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 229940099112 cornstarch Drugs 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-MDZDMXLPSA-N elaidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O ZQPPMHVWECSIRJ-MDZDMXLPSA-N 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 235000003642 hunger Nutrition 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- ISYWECDDZWTKFF-UHFFFAOYSA-N nonadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCCC(O)=O ISYWECDDZWTKFF-UHFFFAOYSA-N 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N pentadecanoic acid Chemical compound CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- SZHOJFHSIKHZHA-UHFFFAOYSA-N tridecanoic acid Chemical compound CCCCCCCCCCCCC(O)=O SZHOJFHSIKHZHA-UHFFFAOYSA-N 0.000 description 2
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 241000276457 Gadidae Species 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 102000001746 Pancreatic alpha-Amylases Human genes 0.000 description 1
- 108010029785 Pancreatic alpha-Amylases Proteins 0.000 description 1
- 239000005643 Pelargonic acid Substances 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- NPTLAYTZMHJJDP-KTKRTIGZSA-N [3-[3-[3-[3-[3-[3-[3-[3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)CO NPTLAYTZMHJJDP-KTKRTIGZSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- 238000003928 amperometric titration Methods 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 229940116224 behenate Drugs 0.000 description 1
- UKMSUNONTOPOIO-UHFFFAOYSA-M behenate Chemical compound CCCCCCCCCCCCCCCCCCCCCC([O-])=O UKMSUNONTOPOIO-UHFFFAOYSA-M 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- AIXAANGOTKPUOY-UHFFFAOYSA-N carbachol Chemical compound [Cl-].C[N+](C)(C)CCOC(N)=O AIXAANGOTKPUOY-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- KJDZDTDNIULJBE-QXMHVHEDSA-N cetoleic acid Chemical compound CCCCCCCCCC\C=C/CCCCCCCCCC(O)=O KJDZDTDNIULJBE-QXMHVHEDSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 108010030727 lens intermediate filament proteins Proteins 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 125000002960 margaryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 229940067631 phospholipid Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000007601 warm air drying Methods 0.000 description 1
Landscapes
- Cereal-Derived Products (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は改質小麦粉の製法に関するものである。特に、
本発明は、従来の小麦粉に比べて消化・吸収の緩やかな
改質小麦粉の製法に関するものである。DETAILED DESCRIPTION OF THE INVENTION (Industrial Application Field) The present invention relates to a method for producing modified wheat flour. especially,
The present invention relates to a method for producing modified wheat flour that is more slowly digested and absorbed than conventional wheat flour.
(従来の技術)
近年、先進社会においては、食生活の豊潤化により肥満
症患者が急増している。肥満度の高い人は、正常体重の
人に比べて糖尿病ζ動脈硬化症、心臓病等に2.3倍か
かりやすく、また痛風や手術後の合併症、胆石症、腰痛
症、肝臓病等肥満と関係の深い病気は増加の一途である
。(Prior Art) In recent years, in advanced societies, the number of obese patients is rapidly increasing due to richer dietary habits. People with a high degree of obesity are 2.3 times more likely to suffer from diabetes, ζ-arteriosclerosis, heart disease, etc. than people with a normal weight, and are also more prone to obesity such as gout, complications after surgery, cholelithiasis, low back pain, and liver disease. The number of diseases closely related to this is increasing.
このように肥満症は健康管理上重大な問題になりつつあ
る。Obesity is thus becoming a serious problem in health management.
このような肥満症の治療および予防の手段としては、従
来は、例えば摂取カロリーを低減させることが考えられ
ていた。しかしながら、摂取量物量を単に低減させただ
けでは、強い飢餓感、空腹感により長続きしないので、
同時にり下の方法がとられている。As a means of treating and preventing obesity, it has been conventionally thought to reduce calorie intake, for example. However, simply reducing the intake amount will not last long due to strong hunger and hunger sensations.
At the same time, the following methods are being used.
その一つは、少量の食物摂取によっても胃に機械的伸展
刺激が加わるように、!内に風船を留置するか、胃の大
部分を閉塞して胃容積を著しく狭める方法である。しか
し、これらの手法は、手術を必要とする恒久的な処置で
あり、しかも副作用等が懸念されるため望ましくない。One of them is that even a small amount of food intake causes a mechanical stretch stimulus to be applied to the stomach! This method involves placing a balloon inside the stomach or occluding most of the stomach to significantly narrow the stomach volume. However, these techniques are not desirable because they are permanent treatments that require surgery, and there are concerns about side effects.
もう一つの方法は、食物繊維等の増量剤、増粘剤を単独
または他の食品に混合して摂取させる方法である。これ
は、食物繊維が難消化性であることを利用し、単位重量
あたりのカロリーを低下させたものである。Another method is to ingest fillers and thickeners such as dietary fiber alone or in combination with other foods. This takes advantage of the fact that dietary fiber is indigestible and reduces the calorie content per unit weight.
そして、消化・吸収の緩やかな糖質を含む食品が抗肥満
に有効であることが報告されている[enkins、
D、 J、 A、 、 et al、 、 As、 J
、 Cl1n、 Nutr、 34 :1IARCH1
981,pp、362−366]。具体的には、ハイア
ミロースコーンスターチを用いるものである。It has also been reported that foods containing carbohydrates that are slowly digested and absorbed are effective against obesity [Enkins,
D, J, A, , et al, , As, J
, Cl1n, Nutr, 34:1IARCH1
981, pp. 362-366]. Specifically, high amylose cornstarch is used.
また、小麦粉に乳化剤を作用させて改質する方法がある
(特公昭59−13177号公報)。この方法は、パン
生地の伸びの改良あるいは老化防止を目的とするものあ
り、消化・吸収を遅延化するものではない。そして、澱
粉質と脂肪酸エステルとの結合物させたものが知られて
いるが、加熱糊化したアミロースと脂肪酸エステルの熱
可逆的な結合を示唆する物であって、糊化した改質小麦
粉により製造された食品は食感が著しく低下する。There is also a method of modifying wheat flour by applying an emulsifier to it (Japanese Patent Publication No. 13177/1983). This method is aimed at improving the spreadability of bread dough or preventing aging, and does not delay digestion or absorption. A combination of starch and fatty acid ester is known, but this suggests a thermoreversible combination of heat-gelatinized amylose and fatty acid ester, and it is produced by gelatinized modified wheat flour. The texture of the manufactured food is significantly reduced.
(発明が解決しようとする課題)
しかしながら、食物繊維は、味、食感が好ましくないた
め、単独での大量摂取は困難であり、食品に添加したも
のであっても、多くの場合、味、食感が著しく低下する
という欠点を有している。また、大量の食物繊維の摂取
は、他の有益な栄養素の吸収を阻害したり、下痢や便秘
を起こす等の副作用があり好ましくない。さらに、上述
のように、ハイアミロースコーンスターチを用いたもの
、加熱糊化したアミロースと脂肪酸エステルの熱可逆的
な結合をしたものを用いた食品は食感が著しく悪いもの
であった。(Problems to be Solved by the Invention) However, dietary fiber has an unfavorable taste and texture, so it is difficult to consume large amounts of it alone, and even when added to food, in many cases the taste and texture It has the disadvantage that the texture is significantly reduced. In addition, ingesting large amounts of dietary fiber is undesirable because it inhibits the absorption of other beneficial nutrients and causes side effects such as diarrhea and constipation. Furthermore, as mentioned above, foods using high amylose corn starch and foods using thermoreversible bonds of heat-gelatinized amylose and fatty acid ester had extremely poor texture.
また、小麦粉は、食品の製造に使用する場合に、加工の
容易性の点より、乾燥状態となっていることが好ましい
。しかし、乾燥工程において、加熱されることにより、
小麦粉が糊化することがある。Furthermore, when the wheat flour is used in the production of foods, it is preferable that the flour be in a dry state from the viewpoint of ease of processing. However, due to heating in the drying process,
Flour may gelatinize.
そこで、本発明の目的は、消化・吸収が緩やかであり、
上記のような低カロリー化によらなくとも、効果的な肥
満の防止または改善が行え、さらに、摂取後の血糖値の
急激な上昇を抑制でき、糖尿病患者などに有効で、かつ
種々の食品の製造に容易に使用できるように乾燥状態と
なっており、さらに通常の小麦粉と同様の味、食感を有
する糊化されていない改質小麦粉の製造方法を提供する
ことを目的とする。Therefore, the purpose of the present invention is to provide slow digestion and absorption;
It is possible to effectively prevent or improve obesity even without reducing calories as described above, and furthermore, it can suppress the rapid rise in blood sugar levels after ingestion, and is effective for diabetics and other people. To provide a method for producing modified wheat flour that is not gelatinized and is in a dry state so that it can be easily used for production, and has the same taste and texture as ordinary wheat flour.
(m題を解決するための手段)
上記目的を達成するものは、原料小麦粉100重量部と
、摂取可能な両親媒性の脂肪酸化合物2〜50重量部と
を溶媒の存在下において、前記原料小麦粉中の澱粉質を
糊化させずに、前記脂肪酸化合物を結合させた後、得ら
れた結合物を40℃未満の温度で乾燥させる改質小麦粉
の製造方法である。(Means for Solving Problem M) To achieve the above object, 100 parts by weight of raw wheat flour and 2 to 50 parts by weight of an ingestible amphipathic fatty acid compound are added to the raw flour in the presence of a solvent. This is a method for producing modified wheat flour, in which the fatty acid compound is bound without gelatinizing the starch therein, and then the resulting bound product is dried at a temperature of less than 40°C.
また、上記目的を達成するものは、原料小麦粉100重
量部と、摂取可能な両親媒性の脂肪酸化合物2〜50重
量部とを、溶媒の10〜10000重量部の存在下にお
いて、前記原料小麦粉中の澱粉質を糊化させずに、前記
脂肪酸化合物を結合させた後、得られた結合物を40℃
未満の温度下で乾燥させる改質小麦粉の製造方法である
。In addition, to achieve the above object, 100 parts by weight of raw wheat flour and 2 to 50 parts by weight of an ingestible amphipathic fatty acid compound are added to the raw flour in the presence of 10 to 10,000 parts by weight of a solvent. After bonding the fatty acid compound without gelatinizing the starch, the resulting bond was heated at 40°C.
This is a method for producing modified wheat flour that is dried at a temperature below
そして、前記乾燥を行った後に、粉砕を行うことが好ま
しい。さらに、前記乾燥は、減圧乾燥、流動層乾燥また
は凍結乾燥により行われることが好ましい。Then, it is preferable to perform pulverization after performing the drying. Furthermore, the drying is preferably performed by vacuum drying, fluidized bed drying, or freeze drying.
そこで、本発明の改質小麦粉の製法について説明する。Therefore, the method for producing modified wheat flour of the present invention will be explained.
本発明の改質小麦粉の製造方法は、原料小麦粉100重
量部と、摂取可能な両親媒性の脂肪酸化合物2〜50重
量部とを溶媒の存在下において、原料小麦粉中の澱粉質
を糊化させずに、脂肪酸化合物を結合させた後、得られ
た結合物を40℃未満の温度で乾燥させるものである。The method for producing modified wheat flour of the present invention involves gelatinizing the starch in the raw wheat flour by adding 100 parts by weight of the raw wheat flour and 2 to 50 parts by weight of an ingestible amphipathic fatty acid compound in the presence of a solvent. After the fatty acid compound is bonded without any process, the resulting bond is dried at a temperature of less than 40°C.
本発明において原料として用いられる小麦粉としては、
粒径0.1〜100μ!程度のものが、後述する脂肪酸
化合物の結合が確実であり好適である。The flour used as a raw material in the present invention includes:
Particle size 0.1-100μ! It is preferable that the bonding of the fatty acid compound described below is ensured.
そして、この製造方法では、まず、小麦粉とを上述のよ
うな両親媒性の脂肪酸化合物を溶媒の存在下に接触させ
る。この工程は、例えば、小麦粉に、予め溶媒に溶解あ
るいは分散させた脂肪酸化合物を添加し、小麦粉と脂肪
酸化合物を溶媒の存在下に接触させ、小麦粉中の澱粉質
に脂肪酸化合物を結合させる。また、溶媒の量は、両親
媒性の脂肪酸化合物および、溶媒の種類によっても左右
されるが、小麦粉100重量部に対し10〜10000
重量部であることが好ましく、より好ましくは、20〜
500重量部である。In this production method, first, wheat flour is brought into contact with the above-mentioned amphiphilic fatty acid compound in the presence of a solvent. In this step, for example, a fatty acid compound that has been previously dissolved or dispersed in a solvent is added to wheat flour, and the wheat flour and the fatty acid compound are brought into contact in the presence of a solvent to bind the fatty acid compound to the starch in the flour. In addition, the amount of solvent depends on the amphipathic fatty acid compound and the type of solvent, but it is 10 to 10,000 parts by weight per 100 parts by weight of wheat flour.
It is preferably 20 to 20 parts by weight, more preferably 20 to 20 parts by weight.
It is 500 parts by weight.
具体的には、溶媒に脂肪酸化合物を添加し、十分に撹拌
した後、溶媒が100重量部以上の場合には、溶媒に小
麦粉を浸漬し、また、溶媒が少ない場合には、小麦粉に
添加し、十分に撹拌する。Specifically, after adding a fatty acid compound to a solvent and stirring thoroughly, if the solvent is 100 parts by weight or more, wheat flour is immersed in the solvent, and if the solvent is small, it is added to the flour. , stir thoroughly.
また、予め溶媒に分散させた小麦粉に改質剤を添加して
、小麦粉と脂肪酸化合物を溶媒の存在下に接触させて、
小麦粉中の澱粉質に脂肪酸化合物を結合させてもよく、
あるいは、小麦粉と改質剤を同時に溶媒に添加して、こ
れらを溶媒に溶解あるいは分散させ、小麦粉と脂肪酸化
合物を溶媒の存在下に接触させて結合させてもよい。溶
媒は、小麦粉および脂肪酸化合物を均一に効率よく接触
させるために添加するものであり、小麦粉になじみ易い
親水性の溶媒であり、かつ脂肪酸化合物を均一に分散さ
せる溶媒であることが望ましい。具体的には、水、アル
コール、グリセリン、アルキレングリコール、アセトン
のいずれか1つまたは2つ以上の混合物を、両親媒性の
脂肪酸化合物の性状によって適宜選択して用いればよい
。In addition, a modifier is added to flour that has been previously dispersed in a solvent, and the flour and fatty acid compound are brought into contact in the presence of the solvent.
A fatty acid compound may be bound to the starch in the flour,
Alternatively, the flour and the modifier may be added to the solvent at the same time, dissolved or dispersed in the solvent, and the flour and the fatty acid compound may be brought into contact and bonded in the presence of the solvent. The solvent is added to uniformly and efficiently contact the flour and the fatty acid compound, and is preferably a hydrophilic solvent that is easily compatible with the flour and a solvent that uniformly disperses the fatty acid compound. Specifically, any one or a mixture of two or more of water, alcohol, glycerin, alkylene glycol, and acetone may be appropriately selected and used depending on the properties of the amphipathic fatty acid compound.
続いて、小麦粉中の澱粉質に両親媒性の脂肪酸化合物を
結合させる工程は、0〜40℃の範囲内にて両者を結合
させることが好ましい。また、上記温度の保持時間とし
ては、上記温度により相違するが、1〜60分程度が好
適である。そして、この結合処理を0〜40℃の範囲内
にて行うことにより、小麦粉中の澱粉質を糊化させるこ
となく、改質することができる。Subsequently, in the step of bonding the amphiphilic fatty acid compound to the starch in the wheat flour, it is preferable to bond the both within the range of 0 to 40°C. Further, the holding time at the above temperature varies depending on the above temperature, but is preferably about 1 to 60 minutes. By performing this binding treatment at a temperature of 0 to 40°C, the starch in the wheat flour can be modified without gelatinization.
続いて、乾燥処理を行う。乾燥方法としては、凍結乾燥
、減圧乾燥(真空乾燥)、流動乾燥、温風乾燥、風乾な
どが考えられる。好ましくは、凍結乾燥、減圧乾燥、流
動層乾燥である。Next, a drying process is performed. Possible drying methods include freeze drying, reduced pressure drying (vacuum drying), fluidized drying, warm air drying, and air drying. Freeze drying, vacuum drying, and fluidized bed drying are preferred.
そして、乾燥温度としては、40”C未満にて行う。The drying temperature is less than 40''C.
このように、40℃未満にて行うことにより、小麦粉中
の澱粉質を糊化させることなく、乾燥することができる
。By performing the drying at a temperature lower than 40° C. in this way, it is possible to dry the flour without gelatinizing the starch in the flour.
本発明に使用される摂取可能な両親媒性の脂肪酸化合物
を構成する脂肪酸としては、カプリル酸、ペラルゴン酸
、カプリン酸、ウンデンル酸、ラウリン酸、トリデシル
酸、ミリスチン酸、ペンタデシル酸、バルミチン酸、ヘ
プタデシル酸、ステアリン酸、ノナデカン酸、アラキン
酸、ベヘン酸、ウンデシレン酸、オレイン酸、エライジ
ン酸、セトレイン酸、エルカ酸、ブラシジン酸、リノー
ル酸、リルン酸、アラキドン酸などのような炭素数8〜
22のものが好ましい。The fatty acids constituting the ingestible amphipathic fatty acid compound used in the present invention include caprylic acid, pelargonic acid, capric acid, undenuric acid, lauric acid, tridecylic acid, myristic acid, pentadecylic acid, valmitic acid, and heptadecyl acid. Acids with carbon atoms ranging from 8 to 8, such as stearic acid, nonadecanoic acid, arachidic acid, behenic acid, undecylenic acid, oleic acid, elaidic acid, cetoleic acid, erucic acid, brassicic acid, linoleic acid, linuric acid, arachidonic acid, etc.
22 is preferred.
脂肪酸塩としては、上記のような脂肪酸のナトリウム塩
、カリウム塩、マグネシウム塩などがアル。また、脂肪
酸化合物としては脂肪酸エステルが好ましく、エステル
のためのアルコール供与体としては、グリセリン、プロ
ピレングリフールないしポリプロピレングリフール類、
シ謬糖およびマルトースなどの糖類、ソルビット、マン
ニット、エリトリット、アラビットなどの糖アルコール
類、グリセロリン酸などがある。Examples of fatty acid salts include the sodium salts, potassium salts, and magnesium salts of the fatty acids listed above. Further, as the fatty acid compound, a fatty acid ester is preferable, and as the alcohol donor for the ester, glycerin, propylene glycol or polypropylene glycol,
These include sugars such as sucrose and maltose, sugar alcohols such as sorbitol, mannitol, erythritol, and arabitol, and glycerophosphoric acid.
摂取可能な両親媒性の脂肪酸化合物を具体的に示すと、
例えば、デカグリセリルモノラウレート、デカグリセリ
ルモノミリステート、ヘキサグリセリルモノステアレー
ト、デカグリセリルモノステアレート、モノグリセリル
モノステアレート、デカグリセリルジステアレート、デ
カグリセリルトリステアレート、デカグリセリルモノオ
レエート、デカグリセリルトリオレエート、ヘキサグリ
セリルモノオレエート、デカグリセリルペンタオレエー
トなどのグリセリン脂肪酸エステル類、ショ糖ステアレ
ート、シロ糖パルミテート、シラ糖オレエート、シ1糖
ラウレート、シ謬糖ベヘネートなどのショ糖脂肪酸エス
テル類、ソルビタンモノラウレート、ソルビタンモノス
テアレート、ソルビタンモノオレエートなどのソルビタ
ン脂肪酸エステル類、レンチン、リゾレシチンなどのリ
ン脂質類カ挙ifられる。なお、このような脂肪酸エス
テルのHL B (Eydorophilic Lip
ophilic Ba1ance)はいずれの領域のも
のを用いてもよい。Specifically, the amphiphilic fatty acid compounds that can be ingested are as follows:
For example, decaglyceryl monolaurate, decaglyceryl monomyristate, hexaglyceryl monostearate, decaglyceryl monostearate, monoglyceryl monostearate, decaglyceryl distearate, decaglyceryl tristearate, decaglyceryl monooleate, Glycerin fatty acid esters such as decaglyceryl trioleate, hexaglyceryl monooleate, and decaglyceryl pentaoleate; sucrose fatty acids such as sucrose stearate, silosaccharide palmitate, silosaccharide oleate, silosaccharide laurate, and sucrose behenate; Examples include esters, sorbitan fatty acid esters such as sorbitan monolaurate, sorbitan monostearate, and sorbitan monooleate, and phospholipids such as lentin and lysolecithin. In addition, HL B (Eydorophilic Lip) of such fatty acid ester
The ophthalmic balance) may be from any region.
本発明に使用される両親媒性の脂肪酸化合物は、小麦粉
中の澱粉質のアミロース部分に結合するものと考えられ
ており、結合したアミロースは、酵素との複合体を形成
しにくい構造となるため澱粉質がアミラーゼ等の消化酵
素による作用を受けにく(なり、このため、消化・吸収
が緩やかになるものと考えられる。そして、脂肪酸化合
物の添加量としては、小麦粉100重量部に対して、2
〜10重量部重量部上り好ましい。The amphiphilic fatty acid compound used in the present invention is thought to bind to the starchy amylose part of wheat flour, and the bound amylose has a structure that makes it difficult to form a complex with enzymes. It is thought that starch is less susceptible to the action of digestive enzymes such as amylase, which slows down digestion and absorption.The amount of fatty acid compounds added is based on 100 parts by weight of wheat flour. 2
Up to 10 parts by weight is preferred.
そして、改質小麦粉中の澱粉質と両親媒性の脂肪酸化合
物の結合比率は、脂肪酸化合物の種類や製造条件によっ
ても異なって(るが、脂肪酸化合物による澱粉質のアミ
ロース占有率が10%以上、特に40〜95%であるこ
とが望ましい。The bonding ratio between starch and amphipathic fatty acid compounds in modified flour varies depending on the type of fatty acid compound and manufacturing conditions (although the ratio of amylose occupancy of starch due to fatty acid compounds to 10% or more is In particular, it is desirable that it be 40 to 95%.
すなわち、脂肪酸化合物による澱粉質のアミロース占有
率が10%以上であれば、消化・吸収速度を確実に遅延
化させることができる。なお、ここでいう「脂肪酸化合
物による澱粉質のアミロース占有率」とは、電流滴定法
を用いたヨウ素親和力(アミロースとヨウ素の結合量)
の測定値より算出されたものである。すなわち、ヨウ素
親和力は、ヨウ素が澱粉中の主としてアミロースと結合
して複合体を形成することを利用してアミロース含量を
推定するものであるが、本発明のように脂肪酸化合物で
澱粉質を処理した場合には、脂肪酸化合物と結合したア
ミロース(ヨウ素を結合しない)の割合だけ未処理の澱
粉質よりもヨウ素親和力が小さくなる。従って、未処理
の澱粉質のヨウ素親和力から処理した澱粉質のヨウ素親
和力を差し引いた値を、未処理の澱粉質のヨウ素親和力
で割った値に100をかけたものが、脂肪酸化合物によ
る澱粉質のアミロース占有率(%)である。That is, if the occupancy rate of starchy amylose by the fatty acid compound is 10% or more, the rate of digestion and absorption can be reliably delayed. Note that the "occupancy rate of amylose in starchy substances by fatty acid compounds" here refers to the iodine affinity (the amount of binding between amylose and iodine) using the amperometric titration method.
It is calculated from the measured value of . In other words, iodine affinity estimates the amylose content by utilizing the fact that iodine mainly binds with amylose in starch to form a complex. In some cases, the iodine affinity is lower than that of untreated starch by the proportion of amylose (which does not bind iodine) bound to fatty acid compounds. Therefore, the value obtained by subtracting the iodine affinity of treated starch from the iodine affinity of untreated starch, divided by the iodine affinity of untreated starch, multiplied by 100 is the value obtained by subtracting the iodine affinity of treated starch from the iodine affinity of untreated starch. It is amylose occupancy (%).
(脂肪酸化合物はるアミロース占有率二%)=[実施例
]
次に、本発明の具体的実施例について説明する。(Amylose occupancy rate of fatty acid compound: 2%) = [Example] Next, specific examples of the present invention will be described.
(実施例1)
市販の小麦粉1に9に、あらかじめショ糖ステアリン酸
エステル(S−1570,三菱化成株式会社製)25g
を分散させた水3Qを添加し、30℃で60分間浸漬さ
せた。次いで、これを30℃で6時間減圧乾燥し、含水
率を1.8%とした。さらに平均粒径0. lxxにな
るまで粉砕処理を行い、改質小麦粉(試料1)を得た。(Example 1) 25 g of sucrose stearate (S-1570, manufactured by Mitsubishi Kasei Corporation) was added to commercially available wheat flour 1 to 9 in advance.
3Q of water in which was dispersed was added and immersed at 30°C for 60 minutes. Next, this was dried under reduced pressure at 30° C. for 6 hours to give a moisture content of 1.8%. Furthermore, the average particle size is 0. The powder was pulverized to lxx to obtain modified wheat flour (sample 1).
(実施例2)
市販の小麦粉509に、グリセリンモノステアリン酸エ
ステル(商品名エマルジーMS、理研ビタミン株式会社
製)259と、水I SxQを加え、30℃で60分間
混線を行った。得られた混線物を、20℃で12時間凍
結乾燥し、含水率を0,1%とした。次いで平均粒径0
.1貢鱈こなるまで粉砕処理を行い、改質小麦粉(試料
2)を得た。(Example 2) Glycerin monostearate ester (trade name Emulgy MS, manufactured by Riken Vitamin Co., Ltd.) 259 and water I SxQ were added to commercially available wheat flour 509, and cross-mixing was performed at 30° C. for 60 minutes. The resulting mixture was freeze-dried at 20° C. for 12 hours to give a moisture content of 0.1%. Then the average particle size is 0
.. The milled cod was pulverized until it became one grain, and modified wheat flour (sample 2) was obtained.
(比較例1)
スプレードライヤー(アシザクニ口株式会社製)を用い
て、50℃で乾燥処理(平均乾燥時間1分)を行う以外
は、実施例1と同様にして改質小麦粉(試料3)を得た
。(Comparative Example 1) Modified wheat flour (sample 3) was produced in the same manner as in Example 1, except that it was dried at 50°C (average drying time: 1 minute) using a spray dryer (manufactured by Ashizakuniguchi Co., Ltd.). Obtained.
(比較例2)
スプレードライヤー(アシザクニ口株式会社製)を用い
て、60℃で乾燥処理(平均乾燥時間1分)を行う以外
は、実施例1と同様にして改質小麦粉(試料4)を得た
。(Comparative Example 2) Modified wheat flour (Sample 4) was produced in the same manner as in Example 1, except that it was dried at 60°C (average drying time 1 minute) using a spray dryer (manufactured by Ashizakuniguchi Co., Ltd.). Obtained.
(比較例3)
スプレードライヤー(アンザクニロ株式会社製)を用い
て、80℃で乾燥処理(平均乾燥時間1分)を行う以外
は、実施例1と同様にして改質小麦粉(試料5)を得た
。(Comparative Example 3) Modified flour (sample 5) was obtained in the same manner as in Example 1, except that a spray dryer (manufactured by Anzakuniro Co., Ltd.) was used for drying at 80°C (average drying time 1 minute). Ta.
(比較例4)
スプレードライヤー(アシザクニ口株式会社製)を用い
て、200℃で乾燥処理(平均乾燥時間1分)を行う以
外は、実施例1と同様にして改質小麦粉(試料6)を得
た。(Comparative Example 4) Modified flour (sample 6) was produced in the same manner as in Example 1, except that it was dried at 200°C (average drying time 1 minute) using a spray dryer (manufactured by Ashizakuniguchi Co., Ltd.). Obtained.
[実験コ
(実験1)
得られた試料1〜6の小麦粉に関して、以下に示す方法
により糊化開始温度、PPA消化性、アミロース占有率
を測定したところ、第1表の通りであった。[Experiment 1 (Experiment 1) Regarding the flour samples 1 to 6 obtained, gelatinization start temperature, PPA digestibility, and amylose occupancy were measured by the methods shown below, and the results were as shown in Table 1.
第1表
本表中−は糊化開始温度が存在せず、既に糊化していた
ことを示す。In Table 1, the symbol "-" indicates that there was no gelatinization start temperature and gelatinization had already occurred.
糊化開始温度の測定は、試料0.19に、精製水を加え
100m(!にメスアップした後、フォトペーストグラ
フィー測定装置[手間理化研究所製]のセルにセットす
る。セル中の試料液を撹拌シながら、2℃/分の昇温速
度で上昇させ、372mmの吸光度を95x(jになる
まで連続的に測定し、吸光度が急激に変化する変曲点に
於ける温度を糊化開始温度とした。To measure the gelatinization start temperature, add purified water to sample 0.19, raise the volume to 100m (!), and then set it in the cell of a photopastegraphy measuring device [manufactured by Tetarika Institute].The sample solution in the cell While stirring, the temperature was increased at a rate of 2°C/min, and the absorbance at 372 mm was continuously measured until it reached 95x (j). Temperature.
PPAによる消化性の測定は、未処理の小麦粉と改質し
た小麦粉のそれぞれの試料0.5gを取り、これに50
mMリン酸緩衝液(p H6,9) 49xQを加え、
次いで37℃に調整した振盪恒温中で30分間放置する
。PPA (ブタすい臓α−アミラーゼ、シグマ社製)
をリン酸緩衝液にて50μU/MQに希釈した酵素液1
wQを加え、反応を開始する。反応開始から0.20
.40.60分後に反応液を0.2zQずつ各2本、0
.IN、NaOH3,8*I2を分注した試験管に入れ
、酵素反応を停止した。To measure digestibility using PPA, take 0.5 g of each sample of untreated wheat flour and modified wheat flour, and add 50 g of each sample.
Add mM phosphate buffer (pH 6,9) 49xQ,
Then, it is left for 30 minutes in a shaking constant temperature adjusted to 37°C. PPA (porcine pancreatic α-amylase, manufactured by Sigma)
Enzyme solution 1 diluted with phosphate buffer to 50μU/MQ
Add wQ to start the reaction. 0.20 from the start of the reaction
.. 40. After 60 minutes, add 2 bottles each of 0.2zQ of the reaction solution, 0.
.. The enzyme reaction was stopped by placing IN, NaOH3,8*I2 into test tubes.
PPAによる消化により生じた還元糖の定量は、ソモギ
ーネルソン法により、行った。なお、この実験では、試
料を予めリン酸緩衝液を加えた後、沸騰湯浴中で30分
間加熱することにより糊化させた後行った。Reducing sugars produced by digestion with PPA were quantified by the Somogyi-Nelson method. In this experiment, a phosphate buffer was added to the sample in advance, and the sample was gelatinized by heating in a boiling water bath for 30 minutes.
アミロース占有率の測定は、試料0.19をアルカリ糊
化させるために20xQの0.5N、KOHを加え、完
全に塊がなくなるまでよく混釈した後、精製水150友
Qを加え、さらにIN、HCffを201Q添加して中
和湿式、総液量を190貢Qとする。調整した試料液9
5xQを冷却しながら、0.4N、K15zQを加え、
25mVの電圧をかけながら、0.00157N、KT
O,で毎分0.5112の速度で滴定し、電流の変化を
測定する。電流が急激に上昇し始める点を変曲点とし、
そのときの滴定量を滴定値とする。一方、同試料0.1
9の全糖量をフェノール・硫酸法により測定しておき、
上述の式に基づき各試料のヨウ素親和力を算出し、さら
に以下の式により脂肪酸化合物による小麦粉中の澱粉質
のアミロース占有率を求めた。To measure the amylose occupancy rate, add 20xQ of 0.5N KOH to alkaline gelatinize sample 0.19, mix well until there are no lumps, add 150% of purified water, and then add IN. , 201Q of HCff is added to neutralize wet method, and the total liquid volume is 190Q. Adjusted sample solution 9
While cooling 5xQ, add 0.4N, K15zQ,
0.00157N, KT while applying a voltage of 25mV
0, at a rate of 0.5112 per minute and measure the change in current. The point where the current starts to rise rapidly is the inflection point,
The titration amount at that time is defined as the titration value. On the other hand, the same sample 0.1
Measure the total sugar content of 9 using the phenol/sulfuric acid method.
The iodine affinity of each sample was calculated based on the above formula, and the occupancy of starchy amylose in wheat flour by fatty acid compounds was determined using the following formula.
[実験2コ
得られた試料1〜6の改質小麦粉それぞれ509と、砂
糖99、ベーキングパウダー159・、乾燥全卵3g、
粉乳49を均一に混合し、さらにバター 2.59、水
60ccを添加し、混合した後、焼成型に流し込み、オ
ーブンで190℃にて30分間焼成し、焼成後、直ちに
型から取り出して室温にまで冷却し、スポンジケーキ(
試料7〜12)を得た。 このようにして得られたス
ポンジケーキに関して、以下に示す方法にて、食感テス
トを行った。その結果を第2表に示す。[Experiment 2 Samples 1 to 6 obtained in Experiment 2 each contained 509 grams of modified flour, 99 grams of sugar, 159 grams of baking powder, 3 grams of dried whole eggs,
Mix 49% of milk powder uniformly, add 2.59% of butter and 60cc of water, and after mixing, pour into a baking mold and bake in an oven at 190℃ for 30 minutes.After baking, immediately remove from the mold and let it cool to room temperature. Cool until the sponge cake (
Samples 7 to 12) were obtained. Regarding the sponge cake thus obtained, a texture test was conducted using the method shown below. The results are shown in Table 2.
第2表
食感テストは、協力者10名に食させ、食感をモニター
した。評価は以下の3段階とした。In the food texture test in Table 2, 10 participants ate the food and monitored the food texture. The evaluation was based on the following three levels.
A・・・・・・ おいしい。B・・・・・・ どちらか
と言えばおいしいが、ややしっとりしている。C・・・
・・・ねっとりとしてまずい。A...It's delicious. B: Rather delicious, but a little moist. C...
...It's sticky and tastes bad.
また、得られたスポンジケーキ(試料7〜12を凍結乾
燥した後、粒径100μ鱈こ粉砕し、さらに、沸騰湯浴
中で30分間加熱することにより、完全に糊化させた後
、実験1と同様の方法にてPPA消化性、アミロース占
有率を測定したところ、実験1における第1表し示した
PPA消化性、アミロース占有率の値とほぼ同じであっ
た。In addition, after freeze-drying the obtained sponge cake (Samples 7 to 12), pulverizing the codfish with a particle size of 100μ, and completely gelatinizing it by heating in a boiling water bath for 30 minutes, Experiment 1 When the PPA digestibility and amylose occupancy were measured in the same manner as above, the values were almost the same as the values of PPA digestibility and amylose occupancy shown in the first table in Experiment 1.
第2表および第1表の結果より、本発明にかかわる改質
小麦粉を用いたスポンジケーキ(試料7〜9)は、食感
も良く、しかも消化・吸収が有為に遅延化されているこ
とがわかった。これに対し、比較例にかかわるスポンジ
ケーキ(試料10〜12)においては、消化・吸収は遅
延化されているものの、著しく食感が劣ることが明らか
となった。From the results in Tables 2 and 1, it can be seen that the sponge cakes (Samples 7 to 9) made using the modified wheat flour according to the present invention have good texture and that digestion and absorption are significantly delayed. I understand. In contrast, in the sponge cakes related to comparative examples (samples 10 to 12), although digestion and absorption were delayed, it became clear that the texture was significantly inferior.
し発明の効果]
本発明の改質小麦粉の製造方法は、原料小麦粉100重
量部と、摂取司能な両親媒性の脂肪酸化合物2〜50重
量部とを溶媒の存在下において、前記原料小麦粉中の澱
粉質を糊化させずに、前記脂肪酸化合物を結合させた後
、得られた結合物を40℃未満の温度で乾燥させる改質
小麦粉の製造方法であり、特に、得られた結合物40℃
未満の温度で乾燥させるものであるので、小麦粉中の澱
粉質を糊化させることなく、乾燥することができる。よ
って、種々の食品の製造に容易に用いることができるよ
うに乾燥状態であり、通常の小麦粉と同様の味、食感を
有する糊化されていない改質小麦粉を効率よく得ること
ができ、さらに、製造された改質小麦粉は、消化・吸収
が緩やかであり、上記のような低カロリー化によらなく
とも、効果的な肥満の防止または改善が行え、さらに、
摂取後の血糖値の急激な上昇を抑制でき、糖尿病患者な
どに有効である。[Effects of the Invention] The method for producing modified wheat flour of the present invention comprises adding 100 parts by weight of raw wheat flour and 2 to 50 parts by weight of an amphiphilic fatty acid compound capable of uptake into the raw flour in the presence of a solvent. A method for producing modified wheat flour, in which the fatty acid compound is bonded without gelatinizing the starch, and then the resulting bond is dried at a temperature of less than 40°C. ℃
Since the flour is dried at a temperature lower than that of the wheat flour, it can be dried without gelatinizing the starch in the wheat flour. Therefore, it is possible to efficiently obtain non-gelatinized modified wheat flour that is in a dry state so that it can be easily used in the production of various foods and has the same taste and texture as ordinary wheat flour. The modified wheat flour produced is slowly digested and absorbed, and can effectively prevent or improve obesity even without reducing the calories as described above.
It can suppress the rapid rise in blood sugar levels after ingestion, making it effective for diabetic patients.
また、本発明の製造方法により得られる改質小麦粉を用
いて製造される食品は、消化・吸収が緩やかであり、か
つ、通常の改質されていない小麦粉を用いた食品と同様
の味および食感を有する。Furthermore, foods produced using the modified wheat flour obtained by the production method of the present invention are slowly digested and absorbed, and have the same taste and texture as foods produced using regular unmodified wheat flour. have a feeling.
Claims (4)
の脂肪酸化合物2〜50重量部とを溶媒の存在下におい
て、前記原料小麦粉中の澱粉質を糊化させずに、前記脂
肪酸化合物を結合させた後、得られた結合物を40℃未
満の温度で乾燥させることを特徴とする改質小麦粉の製
造方法。(1) 100 parts by weight of raw wheat flour and 2 to 50 parts by weight of an ingestible amphiphilic fatty acid compound are added in the presence of a solvent to form the fatty acid compound without gelatinizing the starch in the raw flour. A method for producing modified wheat flour, which comprises, after binding, drying the resulting combined product at a temperature below 40°C.
の脂肪酸化合物2〜50重量部とを、溶媒の10〜10
000重量部の存在下において、前記原料小麦粉中の澱
粉質を糊化させずに、前記脂肪酸化合物を結合させた後
、得られた結合物を40℃未満の温度下で乾燥させるこ
とを特徴とする改質小麦粉の製造方法。(2) 100 parts by weight of raw wheat flour and 2 to 50 parts by weight of an ingestible amphiphilic fatty acid compound are added to 10 to 10 parts by weight of a solvent.
000 parts by weight, the fatty acid compound is bonded without gelatinizing the starch in the raw flour, and the resulting bond is dried at a temperature of less than 40°C. A method for producing modified wheat flour.
は2に記載の改質小麦粉の製造方法。(3) The method for producing modified wheat flour according to claim 1 or 2, wherein pulverization is performed after the drying.
燥により行われるものである請求項1ないし3のいずれ
かに記載の改質小麦粉の製造方法。(4) The method for producing modified wheat flour according to any one of claims 1 to 3, wherein the drying is performed by vacuum drying, freeze drying, or fluidized bed drying.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2262575A JPH04141054A (en) | 1990-09-29 | 1990-09-29 | Preparation of modified wheat flour |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2262575A JPH04141054A (en) | 1990-09-29 | 1990-09-29 | Preparation of modified wheat flour |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04141054A true JPH04141054A (en) | 1992-05-14 |
Family
ID=17377715
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2262575A Pending JPH04141054A (en) | 1990-09-29 | 1990-09-29 | Preparation of modified wheat flour |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04141054A (en) |
-
1990
- 1990-09-29 JP JP2262575A patent/JPH04141054A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2966875B2 (en) | Food material and method for producing the same | |
JPH0463563A (en) | Antiobese food and production thereof | |
JPH0451870A (en) | Anti-obesic food and preparation thereof | |
JP3541200B2 (en) | Method for imparting an effect of preventing obesity and glucose intolerance to food, food and sugar preparation having the same effect | |
JP2016158607A (en) | Bakery food product composition | |
WO2004110174A1 (en) | Composition and foods for lowering glycemic index | |
JPH04141055A (en) | Preparation of modified wheat flour | |
US5300311A (en) | Methods of preparing a modified wheat flour | |
JP2978332B2 (en) | Intestinal metabolism improving food and intestinal metabolism improving agent | |
US5330779A (en) | Material for food and method for production thereof | |
JP4745996B2 (en) | Quality improver for frozen boiled noodles | |
JP2966898B2 (en) | Food material and method for producing the same | |
JPH04141054A (en) | Preparation of modified wheat flour | |
US20230255245A1 (en) | Vegetable fibre hydroysate and its use in human and animal diet | |
JP2018118967A (en) | Immuno-activator | |
JPH04112759A (en) | Modifying agent for rice cooking, cooked rice, modified rice and preparation of cooked rice | |
JPH0463564A (en) | Material for heated and processed food | |
JPH0463561A (en) | Food material and production thereof | |
JP2966897B2 (en) | Food material and method for producing the same | |
JPH04141057A (en) | Production of modified wheat flour | |
JPH0463574A (en) | Material for food and production thereof | |
JPH0463562A (en) | Production of food material | |
JPH04228052A (en) | Material for food and its production | |
JPH0451869A (en) | Food material and preparation thereof | |
JP2955063B2 (en) | Food material and method for producing the same |